Proceeding contribution from Jacob Rees-Mogg (Conservative) in the House of Commons on Monday, 12 July 2010. It occurred during Ministerial statement on NHS White Paper.
NHS White Paper
In welcoming this statement, I wonder whether the Secretary of State will be able to put in place any interim measures for people such as a constituent of mine who have been prescribed life-prolonging cancer drugs such as Lapatinib but are being denied them.
Secondary information
- Type
- Proceeding contribution
- Reference
- 513 c669
- Session
- 2010-12
- Chamber / Committee
- House of Commons chamber
- Subjects
- Access Accountability Cost effectiveness Finance Drugs Innovation Health authorities General practitioners NHS Patients Pay Public expenditure Primary care trusts National Institute for Health and Care Excellence Standards Training Research Productivity Care Quality Commission
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-15 17:36:56 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_654395
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_654395
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_654395